An EMR-based alert helped reduce unnecessary orders for testing for Clostridioides difficile infection in hospitals, according to a study published in Infection Control & Hospital Epidemiology.

Clostridium difficile infection is one of the most common healthcare-associated infections in adults in the United States. Older Americans are especially vulnerable to CDI, 2 and this infection has ...

A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...

Testing for Clostridium difficile infection is significantly lower than expected during diagnosis of inflammatory bowel disease, according to a study in Inflammatory Bowel Diseases, the official ...

Hospitals across the country are being challenged by diagnosing a contagious and deadly superbug. A local lab has a solution to the illness affecting hundreds of thousands of Americans. Clostridium ...

Singulex’s Clarity C. diff toxin A/B assay, a rapid C. diff toxin test, has made its commercial debut, the company announced. “The Clarity toxin A/B assay offers a new approach to testing for C. diff ...

Arlington, Va. — June 27, 2024 — A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C.

A differential blood count is a blood test to check your white blood cell levels, which can indicate the presence of infection, disease, or an allergic reaction. Your doctor might order it as part of ...